ArticleBMC geriatrics2019
A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward.
Article in BMC geriatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 17 citations in OpenAlex.
- Diabetes and cognitive function: An evidence-based current perspective.World journal of diabetes · 2023Review
- Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes.International journal of environmental research and public health · 2023Article
- Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes.Journal of the American Geriatrics Society · 2022Article
- Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.International journal of clinical pharmacy · 2021Article
- Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study.BMJ open diabetes research & care · 2021Observational
- Associations of the Glycaemic Control of Diabetes with Dementia and Physical Function in Rural-Dwelling Older Chinese Adults: A Population-Based Study.Clinical interventions in aging · 2021Article
- Type 2 Diabetes Correlates with Comorbidity and Nutritional Status but Not with Functional Health in Geriatric Ward Patients: A Cross-Sectional Study in Poland.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020Article
- A Retrospective Time Trend Study Of Diabetes Overtreatment In Geriatric Patients.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlycemic control targets in older patients should be individualized according to functional status and comorbidities. The aim of the study was to identify high-risk patients who had evidence of tight glycemic control and thus at risk of serious hypoglycemia.
methodsRetrospective cross-sectional study of type 2 diabetes patients admitted to the geriatric ward receiving diabetes medications. Patients' hospital records were analyzed. The high risk of hypoglycemia group constituted patients who were aged 80+ years, diagnosed with dementia, with end- stage renal disease, or with a history of macrovascular complications. The primary outcome measure was hemoglobin A
resultsTwo hundred thirteen patients were included (77.5% women; 49.3% 80+ year-old). 65.3% received sulfonylurea, 39,4%- metformin, 32.9%- insulin, and 4.2%- acarbose (in 61.5% as monotherapy, and in 38.5% combination therapy). We identified 130 patients (60%) as the denominator for the primary outcome measure; 73.1% had a HbA
conclusionsThe results show a very high rate of tight glycemic control in older patients admitted to the geriatric ward, for whom higher HbA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.